+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report by Analytes (K+, Na+, Cl-, CO2), Disease (Kidney Disease, Diabetes), End-use (Laboratory, PoC), Region, with Growth Forecasts, 2025-2030- Product Image
Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report by Analytes (K+, Na+, Cl-, CO2), Disease (Kidney Disease, Diabetes), End-use (Laboratory, PoC), Region, with Growth Forecasts, 2025-2030- Product Image
New

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report by Analytes (K+, Na+, Cl-, CO2), Disease (Kidney Disease, Diabetes), End-use (Laboratory, PoC), Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 5899606
Description Jump to:
The Comprehensive Metabolic Panel Testing Market was valued at USD 12.58 Billion in 2024, and is projected to reach USD 22.07 Billion by 2030, rising at a CAGR of 9.50%. The rising burden of chronic conditions such as diabetes, kidney disorders, and cardiovascular ailments is the major factor contributing to the market’s growth.

Technological innovations are reshaping diagnostic capabilities, with automated platforms and point-of-care devices enhancing testing speed, accuracy, and accessibility. Advanced systems now integrate AI for data analysis, allowing precise interpretation of results and predictive insights.

Moreover, heightened awareness of preventive care is transforming healthcare consumption patterns. Public health campaigns and policy initiatives emphasize early intervention to curb long-term costs, prompting individuals to prioritize regular metabolic screenings. Insurers are increasingly covering these tests within preventive care packages, reinforcing their adoption.

Comprehensive Metabolic Panel Testing Market Report Highlights

  • Glucose accounted for the largest revenue share of 11.0% in 2024, attributed to the increased emphasis on early detection and preventive healthcare, coupled with lifestyle-related factors such as sedentary habits and poor diets.
  • The K+ segment is expected to grow at the fastest CAGR of 10.0% over the forecast period, owing to rising cases of kidney diseases, cardiovascular disorders, and electrolyte imbalances requiring precise monitoring of K+ levels.
  • The kidney diseases dominated the global comprehensive metabolic panel testing market and accounted for the largest revenue share of 32.4% in 2024, primarily driven by increased incidence of hypertension, diabetes, and obesity, alongside environmental factors such as pollution and dietary salt overconsumption.
  • The diabetes segment is expected to grow at the fastest CAGR of 10.3% over the forecast period, due to technological advancements enabling precise, accessible testing and expanded health insurance coverage for preventive screenings
  • The laboratories segment held the dominant position in the market with the largest revenue share in 2024. The PoC segment is expected to grow at the fastest CAGR of 10.3% from 2025 to 2030.
  • North America dominated the global comprehensive metabolic panel testing market with the largest revenue share in 2024, primarily driven by the high prevalence of chronic diseases such as diabetes, kidney disorders, and cardiovascular conditions, necessitating routine metabolic monitoring.
  • Key companies operating in the global comprehensive metabolic panel testing market include Abbott, Quest Diagnostics, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Analytes
1.2.2. Disease
1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Analytes Outlook
2.2.2. Disease Outlook
2.2.3. End Use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Comprehensive Metabolic Panel Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Global Comprehensive Metabolic Panel Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. Global Comprehensive Metabolic Panel Testing Market: Analytes Business Analysis
4.1. Analytes Segment Dashboard
4.2. Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
4.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, by Analytes, 2018 to 2030 (USD Million)
4.4. K+
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Na+
4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.6. Cl-
4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.7. CO2
4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.8. Glucose
4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.9. BUN
4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.10. Creatinine
4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.11. Ca++
4.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.12. Albumin
4.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.13. Total protein
4.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.14. ALP
4.14.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.15. ALT
4.15.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.16. AST
4.16.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.17. Total bilirubin
4.17.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Comprehensive Metabolic Panel Testing Market: Disease Business Analysis
5.1. Disease Segment Dashboard
5.2. Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
5.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
5.4. Kidney Disease
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Liver Disease
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Diabetes
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Comprehensive Metabolic Panel Testing Market: End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
6.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Laboratory
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Emergency dept.
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Hospital wards
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.4. Primary care
6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.5. Pharmacy
6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.6. Telemedicine
6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. PoC
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. Emergency dept.
6.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.3. Hospital wards
6.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.4. Primary care
6.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.5. Pharmacy
6.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.6. Telemedicine
6.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. PoC (Instruments)
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Piccolo Xpress
6.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.3. Skyla-HB1
6.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.4. DRI-CHEM NX500
6.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.5. Others
6.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Global Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Global Comprehensive Metabolic Panel Testing Market by Region: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key Country Dynamics
7.4.1.2. Regulatory Framework/ Reimbursement Structure
7.4.1.3. Competitive Scenario
7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework/ Reimbursement Structure
7.4.2.3. Competitive Scenario
7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework/ Reimbursement Structure
7.4.3.3. Competitive Scenario
7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Germany
7.5.1.1. Key Country Dynamics
7.5.1.2. Regulatory Framework/ Reimbursement Structure
7.5.1.3. Competitive Scenario
7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework/ Reimbursement Structure
7.5.2.3. Competitive Scenario
7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework/ Reimbursement Structure
7.5.3.3. Competitive Scenario
7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework/ Reimbursement Structure
7.5.4.3. Competitive Scenario
7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework/ Reimbursement Structure
7.5.5.3. Competitive Scenario
7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.6. Denmark
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework/ Reimbursement Structure
7.5.6.3. Competitive Scenario
7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework/ Reimbursement Structure
7.5.7.3. Competitive Scenario
7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.8. Norway
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework/ Reimbursement Structure
7.5.8.3. Competitive Scenario
7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Regulatory Framework/ Reimbursement Structure
7.6.1.3. Competitive Scenario
7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework/ Reimbursement Structure
7.6.2.3. Competitive Scenario
7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework/ Reimbursement Structure
7.6.3.3. Competitive Scenario
7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework/ Reimbursement Structure
7.6.4.3. Competitive Scenario
7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework/ Reimbursement Structure
7.6.5.3. Competitive Scenario
7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework/ Reimbursement Structure
7.6.6.3. Competitive Scenario
7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key Country Dynamics
7.7.1.2. Regulatory Framework/ Reimbursement Structure
7.7.1.3. Competitive Scenario
7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework/ Reimbursement Structure
7.7.2.3. Competitive Scenario
7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. South Africa
7.8.1.1. Key Country Dynamics
7.8.1.2. Regulatory Framework/ Reimbursement Structure
7.8.1.3. Competitive Scenario
7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework/ Reimbursement Structure
7.8.2.3. Competitive Scenario
7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework/ Reimbursement Structure
7.8.3.3. Competitive Scenario
7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework/ Reimbursement Structure
7.8.4.3. Competitive Scenario
7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key Company Heat Map Analysis, 2024
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Quest Diagnostics
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Laboratory Corporation of America Holdings Limited
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Sonic Healthcare
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Unipath
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. SYNLAB International GmbH
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. ARUP Laboratories
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Genoptix Inc.
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Nova Medical
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiative
List of Tables
Table 1 List Of Abbreviations
Table 2 Global Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 3 Global Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 4 Global Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 5 Global Comprehensive Metabolic Panel Testing Market, By Region, 2018-2030 (USD Million)
Table 6 North America Comprehensive Metabolic Panel Testing Market, By Country, 2018-2030 (USD Million)
Table 7 North America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 8 North America Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 9 North America Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 10 U.S. Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 11 U.S. Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 12 U.S. Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 13 Canada Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 14 Canada Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 15 Canada Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 16 Mexico Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 17 Mexico Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 18 Mexico Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 19 Europe Comprehensive Metabolic Panel Testing Market, By Country, 2018-2030 (USD Million)
Table 20 Europe Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 21 Europe Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 22 Europe Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 23 Germany Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 24 Germany Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 25 Germany Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 26 UK Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 27 UK Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 28 UK Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 29 France Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 30 France Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 31 France Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 32 Italy Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 33 Italy Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 34 Italy Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 35 Spain Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 36 Spain Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 37 Spain Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 38 Denmark Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 39 Denmark Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 40 Denmark Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 41 Sweden Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 42 Sweden Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 43 Sweden Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 44 Norway Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 45 Norway Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 46 Norway Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 47 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Country, 2018-2030 (USD Million)
Table 48 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 49 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 50 Asia Pacific Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 51 China Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 52 China Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 53 China Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 54 Japan Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 55 Japan Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 56 Japan Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 57 India Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 58 India Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 59 India Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 60 South Korea Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 61 South Korea Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 62 South Korea Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 63 Australia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 64 Australia Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 65 Australia Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 66 Thailand Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 67 Thailand Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 68 Thailand Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 69 Latin America Comprehensive Metabolic Panel Testing Market, By Country, 2018-2030 (USD Million)
Table 70 Latin America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 71 Latin America Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 72 Latin America Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 73 Brazil Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 74 Brazil Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 75 Argentina Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 76 Argentina Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 77 Argentina Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 78 MEA Comprehensive Metabolic Panel Testing Market, By Region, 2018-2030 (USD Million)
Table 79 MEA Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 80 MEA Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 81 MEA Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 82 South Africa Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 83 South Africa Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 84 South Africa Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 85 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 86 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 87 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 88 UAE Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 89 UAE Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 90 UAE Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
Table 91 Kuwait Comprehensive Metabolic Panel Testing Market, By Analytes, 2018-2030 (USD Million)
Table 92 Kuwait Comprehensive Metabolic Panel Testing Market, By Disease, 2018-2030 (USD Million)
Table 93 Kuwait Comprehensive Metabolic Panel Testing Market, By End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Comprehensive Metabolic Panel Testing Market: Market Outlook
Figure 10 Comprehensive Metabolic Panel Testing Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 Comprehensive Metabolic Panel Testing Market Driver Impact
Figure 16 Comprehensive Metabolic Panel Testing Market Restraint Impact
Figure 17 Comprehensive Metabolic Panel Testing Market Strategic Initiatives Analysis
Figure 18 Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
Figure 19 Comprehensive Metabolic Panel Testing Market: Analytes Outlook and Key Takeaways
Figure 20 K+ Market Estimates and Forecast, 2018-2030
Figure 21 Na+ Market Estimates and Forecast, 2018-2030
Figure 22 Cl- Market Estimates and Forecast, 2018-2030
Figure 23 CO2 Market Estimates and Forecast, 2018-2030
Figure 24 Glucose Market Estimates and Forecast, 2018-2030
Figure 25 BUN Market Estimates and Forecast, 2018-2030
Figure 26 Creatinine Market Estimates and Forecast, 2018-2030
Figure 27 Ca++ Market Estimates and Forecast, 2018-2030
Figure 28 Albumin Market Estimates and Forecast, 2018-2030
Figure 29 Total protein Market Estimates and Forecast, 2018-2030
Figure 30 ALP Market Estimates and Forecast, 2018-2030
Figure 31 ALT Market Estimates and Forecast, 2018-2030
Figure 32 AST Market Estimates and Forecast, 2018-2030
Figure 33 Total bilirubin Market Estimates and Forecast, 2018-2030
Figure 34 Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
Figure 35 Comprehensive Metabolic Panel Testing Market: Disease Outlook and Key Takeaways
Figure 36 Kidney Disease Market Estimates and Forecasts, 2018-2030
Figure 37 Liver Disease Market Estimates and Forecasts, 2018-2030
Figure 38 Diabetes Market Estimates and Forecasts, 2018-2030
Figure 39 Others Market Estimates and Forecasts, 2018-2030
Figure 40 Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
Figure 41 Comprehensive Metabolic Panel Testing Market: End Use Outlook and Key Takeaways
Figure 42 Laboratory Market Estimates and Forecasts, 2018-2030
Figure 43 PoC Market Estimates and Forecasts, 2018-2030
Figure 44 PoC (Instruments) Market Estimates and Forecasts, 2018-2030
Figure 45 Global Comprehensive Metabolic Panel Testing Market: Regional Movement Analysis
Figure 46 Global Comprehensive Metabolic Panel Testing Market: Regional Outlook and Key Takeaways
Figure 47 North America Market Estimates and Forecasts, 2018-2030
Figure 48 U.S. Market Estimates and Forecasts, 2018-2030
Figure 49 Canada Market Estimates and Forecasts, 2018-2030
Figure 50 Mexico Market Estimates and Forecasts, 2018-2030
Figure 51 Europe Market Estimates and Forecasts, 2018-2030
Figure 52 UK Market Estimates and Forecasts, 2018-2030
Figure 53 Germany Market Estimates and Forecasts, 2018-2030
Figure 54 France Market Estimates and Forecasts, 2018-2030
Figure 55 Italy Market Estimates and Forecasts, 2018-2030
Figure 56 Spain Market Estimates and Forecasts, 2018-2030
Figure 57 Denmark Market Estimates and Forecasts, 2018-2030
Figure 58 Sweden Market Estimates and Forecasts, 2018-2030
Figure 59 Norway Market Estimates and Forecasts, 2018-2030
Figure 60 Asia Pacific Market Estimates and Forecasts, 2018-2030
Figure 61 China Market Estimates and Forecasts, 2018-2030
Figure 62 Japan Market Estimates and Forecasts, 2018-2030
Figure 63 India Market Estimates and Forecasts, 2018-2030
Figure 64 Thailand Market Estimates and Forecasts, 2018-2030
Figure 65 South Korea Market Estimates and Forecasts, 2018-2030
Figure 66 Australia Market Estimates and Forecasts, 2018-2030
Figure 67 Latin America Market Estimates and Forecasts, 2018-2030
Figure 68 Brazil Market Estimates and Forecasts, 2018-2030
Figure 69 Argentina Market Estimates and Forecasts, 2018-2030
Figure 70 Middle East and Africa Market Estimates and Forecasts, 2018-2030
Figure 71 South Africa Market Estimates and Forecasts, 2018-2030
Figure 72 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 73 UAE Market Estimates and Forecasts, 2018-2030
Figure 74 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

The companies profiled in this Comprehensive Metabolic Panel Testing market report include:
  • Abbott
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings Limited
  • Sonic Healthcare
  • Unipath
  • SYNLAB International GmbH
  • ARUP Laboratories
  • Genoptix Inc.
  • Nova Medical

Table Information

Report AttributeDetails
No. of Pages100
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 12.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.07 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Comprehensive Metabolic Panel Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Comprehensive Metabolic Panel Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Comprehensive Metabolic Panel Testing - Global Strategic Business Report - Product Image

Comprehensive Metabolic Panel Testing - Global Strategic Business Report

  • Report
  • 385 Pages
  • Global
From
Comprehensive Metabolic Panel Testing Market by Product Type, End User, Testing Type, Distribution Channel, Application, Sample Type, Test Mode - Global Forecast to 2030 - Product Image

Comprehensive Metabolic Panel Testing Market by Product Type, End User, Testing Type, Distribution Channel, Application, Sample Type, Test Mode - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Comprehensive Metabolic Panel (CMP) Testing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Comprehensive Metabolic Panel (CMP) Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Metabolic Testing Solutions Market by Product Type, Test Type, Measurement Parameter, Age Group, Portability, Application, End User - Global Forecast to 2030 - Product Image

Metabolic Testing Solutions Market by Product Type, Test Type, Measurement Parameter, Age Group, Portability, Application, End User - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.